Interact with analyzed results from over 150 RBPs with complimentary ENCODE datasets by Eclipsebio. All reports contain data for peaks and motif information specific for your RBP of interest. Visualize data your way and compare your own results to ENCODE.
A successful eCLIP experiment is heavily dependent on the quality of the antibody. Commercial IP-validated antibodies tend to fail validation due to eCLIP’s stringent washes. Eclipsebio & Cell Signaling Technology (CST) have partnered to expertly validate CST antibodies.
Ready to start your RBP-eCLIP experiment? See Eclipsebio's full list of pre-validated antibodies
See the full protocol on preparing your tissue samples
See the protocol for preparing your adherent cell samples
See the protocol for preparing your suspension cell samples
5' End-Seq facilitates active transcript end detection, enrichment and mapping, and identifies known and novel transcription start sites at single nucleotide resolution in only 2 days.
Enhanced crosslinking and immuno-precipitation followed by high-throughput sequencing (eCLIP) was developed to provide a robust and reproducible framework to map RBP binding sites on RNAs transcriptome-wide.
Explore your ribosome insights interactively, see the example report for eRibo Pro™
eSHAPE db-K562 is a deep sequencing database containing in cellulo and in vitro SHAPE data, as well as ∆SHAPE data from the K562 cell line. The eSHAPE db-K562 is based on 6 technical replicates of polyA-selected RNA and is delivered as a data package for a single gene of interest, sets of genes, or the entire (covered) transcriptome.
3' End-Seq is a technology for defining 3' ends of transcripts by sequencing from the PAS. 3' End-Seq can identify high confidence, known and novel PAS at single nucleotide resolution in 2 days
